Skip to content


Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More


As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More


Latest on Federal Issues

This blog will feature weekly updates from our Socioeconomic Committee and Health Policy team to…

Read more

Physicians Urge MedPAC To Recommend Inflation-Based Medicare Payment Update To Replace Current Law

From the AMA Advocacy Update Newsletter, May 17, 2024 In a letter (PDF) to the Medicare Payment…

Read more

CMS Updates Conversion Factor for Physician Services

In early March, Congress adopted legislation that updated the Medicare Physician Fee Schedule (MPFS) conversion factor for…

Read more

Upcoming Dates

04/01/24: Fellow Exam Application Deadline
Learn more

06/01/24: Research Grant Cycle
Learn more

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more


AAOA Basic Course

Join us from July 25-27 at the hybrid 2024 AAOA Basic Course. As a hybrid course, we are excited to offer both live in-person and virtual participation. The course content will be accessible for over 90 days to help you maximize value. Register Today 


For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More


Available Now


IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Register

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register 

2025 AAOA Advanced Course in Allergy & Immunology - Hybrid
March 27-29, 2025
The Hythe, Vail, CO
Book Your Room

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Release October 1, 2024

News and Updates

CEO Update, June 2024

Does it seem like everything old is new again? The 70s seem to be back…

Read more

CEO Update, May 2024

Can you believe we just celebrated Memorial Day and are heading into summer? I am…

Read more
College Allergy Symptoms Treatment Back to Shcool


AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More


AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>


Hypoallergenic Pet Food: Myth or Magic Solution?

By Alfred Sassler, DO, AAOA PPR Commitee

A major pet food producer is marketing a “groundbreaking” cat food to reduce cat allergens. It was released after 10 years of development and testing to produce a nutritional solution to reduce house cat allergy production. It even comes in a variety of tantalizing, and nutritionally sound, flavor choices according to the manufacturer.

Is this too good to be true?

The main cat antigen

Fel d 1 is the small glycoprotein antigen that is most important for cat allergic people. The antigen is small enough to float in the air and also quite sticky.  It is concentrated in saliva and sebaceous gland secretions allowing cats to spread it to the haircoat when grooming. It is subsequently distributed into the air and can stick to fabrics or other surfaces. When cat allergic people contact Fel d 1, allergy symptoms and asthma exacerbations can occur.

Blocking antibodies

Antibodies that block the immunologic activity of specific antigens are called blocking antibodies. Chicken eggs can be induced to produce IgY blocking antibody for Fel d 1 that is active in cat saliva. These IgY antigens have already been used in animal feed for other conditions. Why not try this for cat antigen?

IgY against Fel d 1 was added to cat food to block the activity of Fel d 1 in the cat’s saliva.

Impact of adding Fel d 1 IgY antibodies to cat food

The company reports a median reduction on 47% of active antigen in 6 weeks. In cats that produced higher levels of Fel d 1, the reduction was even higher. There were no adverse health impacts for the cats.

Is this reduction enough to help with symptoms?

We who treat allergy will usually explain to patient’s that if they can cut down the exposure to their specific allergens, they will have less reactivity (fewer symptoms). However, there is an old adage that a patient is more likely to get rid of their Allergist than their beloved pet!  

Additionally, animal removal is not completely effective as Fel d 1 has been detected up to 9 months after removal.  For example, in a rigorous 2003 study by a group from Iceland, (Bjornsdottir and colleagues) a group of volunteer families strictly followed very stringent environmental control measures while keeping their pets in the home.  These included washing walls and floors, removing carpeting from bedrooms, keeping closets closed, vacuuming floors, carpets and upholstered furniture weekly, applying tannic acid (3%) to carpeting and furniture every 2 months, hot water washing of bedding, replacing old duvets and pillows with polyester filled new ones, hypoallergenic covers on pillows and mattresses, washing the cat every 2 weeks, keeping cat out of bedroom and sleeping with bedroom windows open.  After 8 months, the amount of Fel d1 in the houses decreased by 6.8%. 

While this may not seem like a lot, it did result in significant symptom improvement for the cat allergy sufferers.  The mean nasal peak inspiratory flow increased from 154.9ml to 216.7ml at the 8-month conclusion of the study.  There were also measurable improvements in symptoms of congestion, runny nose and itching. 


This new cat food may actually cut down on allergen exposure and symptoms. However, much of the existing available data is from the company itself with limited prospective data on the clinical impact of this cat food on the symptoms of cat allergic patients.

Given the marketing and branding of this cat food, patients are likely to ask about it so we should be familiar with the available data. It is a low-risk option to try for cat allergic patients seeking additional methods to reducing their symptoms. This food is about 5 times more expensive than other options available from the same company (~ $5 per pound of dry food versus $1 per pound).

The Claim“Groundbreaking” new cat food that is safe and effective at reducing production of cat allergens.
The ScienceIgY chicken egg-derived blocking antigens have been used in other animal feeds for other conditions. Fel d 1 IgY blocking antigens have been shown to reduce production and activity of Fel d 1. The company reported a mean 47% decrease in active Fel d 1 in saliva at 6 weeks
Other OptionsStrict environmental controls à 6.8% decrease in Fel d 1Controls included: washing walls and floors, removing carpeting from bedrooms, weekly vacuuming of carpets and upholstered surfaces, applying tannic acid (3%) to carpeting and furniture every 2 months, hot water washing of bedding, replacing old duvets and pillows with polyester filled new ones, hypoallergenic covers on pillows and mattresses, washing the cat every two weeks, keeping cat out of bedroom, and sleeping with bedroom windows openStrict environmental control improved:Mean nasal peak inspiratory flow increased from 154.9ml to 216.7mlSymptoms of congestion, runny nose, and itching. 
The VerdictNo definitive evidence of clinical efficacy in our patientsUnlikely to harm our patients (or their pets) and may helpThe special cat food is significantly more expensive than other options from the same company


Satyaraj, E., Gardner, C., Filipi, I., Cramer, K. & Sherrill, S. (2019). Reduction of active Fel d 1 from cats using an antiFel d 1 egg IgY antibody. Immunity, Inflammation & Disease. Advance online publication. doi: 10.1002/iid3.244

Matulka RA, Thompson L, Corley D. Multi-Level Safety Studies of Anti Fel d 1 IgY Ingredient in Cat Food. Front Vet Sci. 2020 Jan 8;6:477. doi: 10.3389/fvets.2019.00477. PMID: 31970163; PMCID: PMC6960183.

Satyaraj E, Gardner C, Filipi I, Cramer K, Sherrill S. Reduction of active Fel d1 from cats using an antiFel d1 egg IgY antibody. Immun Inflamm Dis. 2019 Jun;7(2):68-73. doi: 10.1002/iid3.244. Epub 2019 Mar 9. PMID: 30851084; PMCID: PMC6485700.

Back To Top